Cargando…
Non-gestational choriocarcinoma with hyperprogression on pembrolizumab: A case report and review of the literature
Non-gestational choriocarcinoma is a rare and aggressive germ cell tumor. Here we present the case of a post-menopausal 49-year-old woman who presented with metastatic disease and initially achieved a complete radiographic and biomarker response with seven cycles of EMA-CO chemotherapy. Upon recurre...
Autores principales: | Kazemi, Nazanin Yeganeh, Langstraat, Carrie, John Weroha, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789587/ https://www.ncbi.nlm.nih.gov/pubmed/35111894 http://dx.doi.org/10.1016/j.gore.2022.100923 |
Ejemplares similares
-
A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab
por: Goldfarb, Jennifer A., et al.
Publicado: (2020) -
Pure primary non-gestational choriocarcinoma originating in the ovary: A case report and literature review
por: Yu, Xiujie, et al.
Publicado: (2021) -
Non-gestational choriocarcinoma of the ovary: A case report
por: Yee, Loh S., et al.
Publicado: (2021) -
Ovarian ectopic pregnancy misdiagnosed as gestational choriocarcinoma: A case report()
por: Kazemi, Seyyedeh Neda, et al.
Publicado: (2022) -
Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: An autopsy case study
por: Tanaka, Yuko, et al.
Publicado: (2019)